{"id":"https://openalex.org/W64848736","doi":"https://doi.org/10.1007/978-1-59259-383-5_5","title":"Radiolabeled Monoclonal Antibodies","display_name":"Radiolabeled Monoclonal Antibodies","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W64848736","doi":"https://doi.org/10.1007/978-1-59259-383-5_5","mag":"64848736"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-59259-383-5_5","doi":"https://doi.org/10.1007/978-1-59259-383-5_5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/978-1-59259-383-5_5","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologic Therapy of Leukemia","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W564863316","display_name":"Biologic Therapy of Leukemia"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/978-1-59259-383-5_5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061916244","display_name":"John M. Burke","orcid":"https://orcid.org/0000-0002-5144-6710","observed_orcids":["https://orcid.org/0000-0002-5144-6710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Burke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055703943","display_name":"Joseph Gerard Jurcic","orcid":"https://orcid.org/0000-0002-1671-9998","observed_orcids":["https://orcid.org/0000-0002-1671-9998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph G. Jurcic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03064275,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"59","last_page":"77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radiolabeled-monoclonal-antibodies","display_name":"radiolabeled monoclonal antibodies","score":0.9369999766349792},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8880000114440918},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.9869999885559082},{"id":"https://openalex.org/keywords/membrane-attack-complex","display_name":"membrane attack complex","score":0.8289999961853027},{"id":"https://openalex.org/keywords/fc-receptors","display_name":"Fc receptors","score":0.7250000238418579},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.7850000262260437},{"id":"https://openalex.org/keywords/anti-cd52-antibody","display_name":"anti-CD52 antibody","score":0.753000020980835},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/chimeric-antibodies","display_name":"chimeric antibodies","score":0.6460000276565552},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.75},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8445645570755005},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7078366279602051},{"id":"https://openalex.org/C2778384904","wikidata":"https://www.wikidata.org/wiki/Q21108353","display_name":"CD52","level":4,"score":0.5833053588867188},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5587274432182312},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5577505230903625},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5013296604156494},{"id":"https://openalex.org/C2777843201","wikidata":"https://www.wikidata.org/wiki/Q17163357","display_name":"Monoclonal antibody therapy","level":4,"score":0.4954434633255005},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47619402408599854},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4724619388580322},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4165252149105072},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40527012944221497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3215409517288208},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2658585011959076},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08831408619880676},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/978-1-59259-383-5_5","doi":"https://doi.org/10.1007/978-1-59259-383-5_5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/978-1-59259-383-5_5","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologic Therapy of Leukemia","raw_type":"book-chapter"},{"id":"doi:10.1385/1-59259-383-6:59","doi":"https://doi.org/10.1385/1-59259-383-6:59","is_oa":false,"landing_page_url":"http://doi.org/10.1385/1-59259-383-6:59","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologic Therapy of Leukemia","raw_type":"book-chapter"},{"id":"mag:64848736","doi":null,"is_oa":false,"landing_page_url":"https://link.springer.com/chapter/10.1007/978-1-59259-383-5_5","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1007/978-1-59259-383-5_5","doi":"https://doi.org/10.1007/978-1-59259-383-5_5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/978-1-59259-383-5_5","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologic Therapy of Leukemia","raw_type":"book-chapter"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W100467445","https://openalex.org/W124412411","https://openalex.org/W267300006","https://openalex.org/W1557532626","https://openalex.org/W1559765420","https://openalex.org/W1576593419","https://openalex.org/W1593737248","https://openalex.org/W1710740437","https://openalex.org/W1730814954","https://openalex.org/W1772206618","https://openalex.org/W1833241997","https://openalex.org/W1842764967","https://openalex.org/W1852191222","https://openalex.org/W1885988951","https://openalex.org/W1942856476","https://openalex.org/W1944965129","https://openalex.org/W1967760353","https://openalex.org/W1973018895","https://openalex.org/W1985221571","https://openalex.org/W1997928845","https://openalex.org/W2036479586","https://openalex.org/W2037927415","https://openalex.org/W2060982877","https://openalex.org/W2080585386","https://openalex.org/W2096057211","https://openalex.org/W2109581986","https://openalex.org/W2120818780","https://openalex.org/W2123987346","https://openalex.org/W2134668264","https://openalex.org/W2154789907","https://openalex.org/W2166118327","https://openalex.org/W2171140185","https://openalex.org/W2171749120","https://openalex.org/W2188221592","https://openalex.org/W2215316452","https://openalex.org/W2256690185","https://openalex.org/W2267583049","https://openalex.org/W2269690597","https://openalex.org/W2273204150","https://openalex.org/W2294409256","https://openalex.org/W2335889607","https://openalex.org/W2347139417","https://openalex.org/W2405785190","https://openalex.org/W2413934360","https://openalex.org/W2415300558","https://openalex.org/W2418291002","https://openalex.org/W2440288526","https://openalex.org/W2468311462"],"related_works":["https://openalex.org/W182711793","https://openalex.org/W72219410","https://openalex.org/W2140177945","https://openalex.org/W1976220274","https://openalex.org/W2043507805","https://openalex.org/W6982722","https://openalex.org/W2041021284","https://openalex.org/W1621402431","https://openalex.org/W2883425082","https://openalex.org/W2009673033"],"abstract_inverted_index":{"By":[0],"targeting":[1],"therapy":[2],"to":[3,71,85,143,150],"specific":[4],"cell":[5,88,118,126,137],"types":[6],"and":[7,19,108,147,171],"disease":[8],"sites,":[9],"monoclonal":[10],"antibodies":[11,157],"(MAbs)":[12],"offer":[13],"the":[14,27,31,53,60,101,109,112,152,165,172],"possibility":[15],"of":[16,30,48,62,82,103,111,156],"improved":[17],"efficacy":[18],"decreased":[20],"toxicity":[21],"compared":[22],"with":[23,158],"conventional":[24],"chemotherapy.":[25],"Nonetheless,":[26],"optimistic":[28],"view":[29],"early":[32],"1980s":[33,54],"that":[34,116],"MAbs":[35,58,67],"were":[36],"\u201cmagic":[37],"bullets\u201d":[38],"has":[39],"now":[40],"been":[41],"replaced":[42],"by":[43],"a":[44,77,83,86,144],"more":[45],"realistic":[46],"understanding":[47],"their":[49],"therapeutic":[50],"potential.":[51],"Since":[52],"various":[55],"strategies":[56],"employing":[57],"for":[59,105,124,177],"treatment":[61],"cancer":[63],"have":[64],"evolved.":[65],"Native":[66],"can":[68,89],"be":[69],"used":[70],"focus":[72],"an":[73,135,139],"inflammatory":[74],"response":[75],"against":[76],"tumor":[78,125],"cell.":[79,154],"The":[80],"binding":[81],"MAb":[84,146],"target":[87,153],"result":[90],"in":[91,133],"complement":[92],"activation,":[93],"thereby":[94],"initiating":[95],"several":[96],"biologically":[97],"important":[98,122],"effects,":[99],"including":[100],"induction":[102],"chemotaxis":[104],"phagocytic":[106],"cells":[107],"production":[110],"membrane":[113,119],"attack":[114],"complex":[115],"disrupts":[117],"integrity.":[120],"Anther":[121],"mechanism":[123],"killing":[127],"is":[128,148],"antibody-dependent":[129],"cell-mediated":[130],"cytotoxicity":[131],"(ADCC),":[132],"which":[134],"effector":[136],"expressing":[138],"Fc":[140],"receptor":[141],"binds":[142],"cell-bound":[145],"triggered":[149],"kill":[151],"Examples":[155],"intrinsic":[159],"immunologically":[160],"mediated":[161],"antitumor":[162],"activity":[163],"include":[164],"chimeric":[166],"anti-CD20":[167],"antibody":[168,175],"rituximab":[169],"(1)":[170],"humanized":[173],"anti-CD52":[174],"CAMPATH-1H":[176],"chronic":[178],"lymphocytic":[179],"leukemia":[180],"(CLL)":[181],"(2).":[182]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}